Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction Elaine Monteiro Matsuda; Ivana Barros Campos; Isabela Penteriche de Oliveira; Daniela Rodrigues Colpas; Giselle Ibete Silva López-Lopes; Victor Oliveira Chiavegato; Luís Fernando de Macedo Brígido;

Risk factors for severe COVID-19 infection in Brazilian children Jordana Vaz Hendler; Patricia Miranda do Lago; Gabriel Cardozo Müller; João Carlos Santana; Jefferson Pedro Piva; Liane Esteves Daudt;

Impact of maintenance immunosuppression regimen on anti-SARS-CoV-2 antibody and cellular kinetics in kidney transplant recipients receiving ChAdOx1 as primary vaccination Julia Soares Reis; Roberto Matias Souza; Helio Tedesco-Silva; Lúcio Requião-Moura; José Medina Pestana; Renato Demarchi Foresto;